Developing Clinical Messages in a Value-Driven Market Can Support Appropriate Evidentiary Interpretation and Translation in the U.S.
Posted: January 2, 2013
By: Avalere Health LLC
This paper explores the role of robust “clinical value messaging” in enhancing evidence-based care and encouraging appropriate practice changes in a way that is beneficial to providers, payers, manufacturers, and patients. Specifically, we evaluate how strong clinical value messages can potentially shorten the time it takes for external stakeholders to assess new product data, and may ultimately affect the coverage policies for and use of a new product. While this evaluation is U.S.-based and highlights issues specific to our healthcare system, the concept of clinical value messaging is almost certainly relevant to those countries experiencing similar challenges.
Share this content with your network.
By clicking this 'Download Now' box, you consent to BioCentury forwarding your information
to the company that wrote this White Paper and you agree that said company can use